Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.

Ashtari F, Shaygannejad V, Akbari M.

Acta Neurol Scand. 2008 Nov;118(5):301-5. doi: 10.1111/j.1600-0404.2008.01087.x.

PMID:
18713156
2.

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group.

Cephalalgia. 2007 Jul;27(7):814-23. Epub 2007 Apr 18. Erratum in: Cephalalgia. 2007 Aug;27(8):962.

PMID:
17441971
3.

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J; Topiramate Chronic Migraine Study Group.

Headache. 2007 Feb;47(2):170-80.

PMID:
17300356
4.

Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.

Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J; CAPSS-277 Investigator Group.

Clin Ther. 2009 Mar;31(3):542-59. doi: 10.1016/j.clinthera.2009.03.020.

PMID:
19393844
5.

Topiramate as an adjunctive treatment in migraine prophylaxis.

Martínez HR, Londoño O, Cantú-Martínez L, del Carmen Tarín L, Castillo CD.

Headache. 2003 Nov-Dec;43(10):1080-4.

PMID:
14629243
6.
7.

Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.

Mohammadianinejad SE, Abbasi V, Sajedi SA, Majdinasab N, Abdollahi F, Hajmanouchehri R, Faraji A.

Clin Neuropharmacol. 2011 Jul-Aug;34(4):174-7. doi: 10.1097/WNF.0b013e318225140c.

PMID:
21738025
8.

Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.

Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V.

Headache. 2006 Apr;46(4):642-8.

PMID:
16643559
9.

Topiramate in migraine prevention: results of a large controlled trial.

Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group.

Arch Neurol. 2004 Apr;61(4):490-5.

PMID:
15096395
10.

Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.

Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.

Headache. 2009 Sep;49(8):1153-62. doi: 10.1111/j.1526-4610.2009.01508.x.

PMID:
19719543
11.

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.

Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, Kurland CL, Nye J, Yuen E, Eerdekens M, Ford L.

Pediatrics. 2009 Mar;123(3):924-34. doi: 10.1542/peds.2008-0642.

PMID:
19255022
12.

A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.

Afshari D, Rafizadeh S, Rezaei M.

Int J Neurosci. 2012 Feb;122(2):60-8. doi: 10.3109/00207454.2011.626908. Epub 2011 Nov 2.

PMID:
21950578
13.

Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.

Lakshmi CV, Singhi P, Malhi P, Ray M.

J Child Neurol. 2007 Jul;22(7):829-35.

PMID:
17715274
14.

Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).

Gupta P, Singh S, Goyal V, Shukla G, Behari M.

Headache. 2007 Mar;47(3):402-12.

PMID:
17371357
15.

Long-term migraine prevention with topiramate: open-label extension of pivotal trials.

Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.

Headache. 2006 Jul-Aug;46(7):1151-60.

PMID:
16866719
16.

A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.

Mathew NT, Jaffri SF.

Headache. 2009 Nov-Dec;49(10):1466-78. doi: 10.1111/j.1526-4610.2009.01566.x.

PMID:
19912346
17.

Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.

Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J; Topiramate Pediatric Migraine Study Investigators.

Headache. 2005 Nov-Dec;45(10):1304-12.

PMID:
16324162
18.

Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.

Mathew NT, Kailasam J, Meadors L.

Headache. 2002 Sep;42(8):796-803.

PMID:
12390644
19.

Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine.

Silberstein SD, Dodick DW, Lindblad AS, Holroyd K, Harrington M, Mathew NT, Hirtz D; Chronic Migraine Treatment Trial Research Group.

Neurology. 2012 Mar 27;78(13):976-84. doi: 10.1212/WNL.0b013e31824d5846. Epub 2012 Feb 29.

20.

Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.

Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.

Headache. 2012 May;52(5):749-64. doi: 10.1111/j.1526-4610.2011.02054.x. Epub 2011 Dec 21.

PMID:
22188311

Supplemental Content

Support Center